Pengaruh Leverage, Pertumbuhan Perusahaan, Ukuran Perusahaan, Risk Profile dan Profitabilitas Terhadap Nilai Perusahaan
Jurnal Inovasi Akuntansi (JIA) · 2023
DOI: 10.36733/jia.v1i1.6884 ↗Kurz gefasst
Fachartikel in der Zeitschrift Jurnal Inovasi Akuntansi (JIA), 2023. Verfasst von Kadek Meilyana Syahrani und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This study aims to determine and test the effect of leverage, growth, size, risk profile, and profitability, on firm value in banking companies listed on the Indonesia Stock Exchange (IDX) for the 2019-2021 period. The research population is banking companies listed on the Indonesia Stock Exchange for the 2019-2021 period. The sample in this study were 41 banking companies which were determined based on the purposive sampling method. The analysis technique used in this study is multiple linear regression analysis. Based on the results of the study, it shows that leverage has no effect on firm value, growth has a positive effect on firm value, size has a positive effect on firm value, risk profile has no effect on firm value, and profitability has a positive effect on firm value.
Zitieren
APA
Syahrani, K. M., Merawati, L. K., & Tandio, D. R. (2023). Pengaruh Leverage, Pertumbuhan Perusahaan, Ukuran Perusahaan, Risk Profile dan Profitabilitas Terhadap Nilai Perusahaan. Jurnal Inovasi Akuntansi (JIA). https://doi.org/10.36733/jia.v1i1.6884
Vancouver
Syahrani KM, Merawati LK, Tandio DR. Pengaruh Leverage, Pertumbuhan Perusahaan, Ukuran Perusahaan, Risk Profile dan Profitabilitas Terhadap Nilai Perusahaan. Jurnal Inovasi Akuntansi (JIA). 2023. doi:10.36733/jia.v1i1.6884
BibTeX
@article{Syahrani2023,
author = {Syahrani, Kadek Meilyana and Merawati, Luh Komang and Tandio, Daniel Raditya},
title = {Pengaruh Leverage, Pertumbuhan Perusahaan, Ukuran Perusahaan, Risk Profile dan Profitabilitas Terhadap Nilai Perusahaan},
journal = {Jurnal Inovasi Akuntansi (JIA)},
year = {2023},
doi = {10.36733/jia.v1i1.6884}
}
EUVIMED